Patients who underwent a stem cell transplant and received the Triplex vaccine to prevent a type of herpes virus—cytomegalovirus (CMV) - from duplicating out of control were 50% less likely to develop health complications related to the virus than patients who did not take Triplex, according to a City of Hope-led study published today in Annals of Internal Medicine.
* This article was originally published here
